This October, the global plastic surgery community will gather in Cancún for ISAPS World Congress 2026 — and BioScience will be part of the conversation.
From 28–31 October, attendees will come together at the Cancun Center for scientific exchange, evolving techniques, and new perspectives across aesthetic plastic surgery.
For BioScience, one discussion will take centre stage: the growing role of multimodal treatment planning in gluteal augmentation.
Gluteal augmentation is not simply a question of adding volume. Shape, projection, surrounding proportions, existing anatomy, and individual treatment goals can all influence the final result — and no single technique answers every clinical need.
Fat transfer remains an established option within surgical body contouring, while hyaluronic acid body fillers introduce a different approach to targeted correction.
At ISAPS Cancún, Dr. Kai O. Kaye will bring these two perspectives into the same discussion.
Rather than asking which modality is universally better, the session will explore a more relevant question for modern practice: how can treatment selection become more customised to the individual patient?
Every patient presents with different anatomy. One may be looking for greater projection, while another may be more concerned with lateral contour, hip depressions, asymmetry or the transition between the waist, hips and gluteal region.
These differences matter.
They influence not only the desired result, but also how a practitioner approaches treatment planning and which modality may be appropriate.
As expectations around body aesthetics continue to evolve, this more individualised approach is becoming increasingly relevant — particularly for surgeons looking beyond a standardised treatment pathway.
The relationship between surgery and injectable aesthetics is becoming increasingly interesting within body treatments.
HA body fillers, including HYAcorp, BioScience's range developed for body-contouring applications, offer a different set of possibilities from fat transfer. They also come with their own considerations around anatomy, product selection, treatment area, and patient suitability.
That does not mean one needs to replace the other.
Instead, the discussion is beginning to centre on where each approach may fit — individually or as part of a broader strategy.
For plastic surgeons already working with fat grafting and gluteal procedures, this creates an opportunity to look at body fillers from a different perspective.
The appearance of the buttocks is influenced by more than the gluteal region itself.
The relationship between the waist, lateral hips, hip dips, and surrounding contours can all affect overall shape and proportion.
This makes anatomical assessment particularly important when planning gluteal enhancement.
Rather than focusing only on how much volume is added, treatment planning can consider where correction is needed and how that change affects the wider silhouette.
It is this more complete view of gluteal aesthetics that makes customised treatment strategies especially relevant.
ISAPS World Congress brings together an international audience of plastic surgeons to exchange clinical perspectives and explore how aesthetic surgery continues to evolve.
For those working in gluteal augmentation, fat transfer, body contouring or injectable aesthetics, the boundaries between treatment categories are becoming less rigid.
More options can create more flexibility — but they also make clinical judgement, patient selection and anatomical understanding increasingly important.
BioScience's Open Stage session will bring these considerations into one focused discussion, connecting established surgical practice with emerging possibilities in injectable body aesthetics.
Whether you want to catch the Open Stage discussion or connect with the team directly, there will be several opportunities to meet BioScience throughout the congress.
Visit BioScience at booth 42 & 44 to learn more, speak with the team, and continue the conversation around body contouring, injectable aesthetics, and evolving treatment strategies.
Don’t forget to join us for:
Dr. Kai O. Kaye
Thursday, 29 October 2026
13:00–13:15 | Open Stage 2
A focused 15-minute discussion on how fat transfer, HA fillers, and individualised treatment planning are beginning to intersect in modern gluteal augmentation.
Whether you stop by the booth or join us at the Open Stage, make BioScience part of your ISAPS Cancún schedule.
Yes. BioScience will be present at ISAPS World Congress 2026 in Cancún, including a dedicated Industry Open Stage session.
The session will explore fat transfer and hyaluronic acid fillers in customised gluteal augmentation, with a focus on how different treatment modalities may fit within individualised treatment strategies.
The session will be presented by Dr. Kai O. Kaye.
The session takes place on Thursday, 29 October 2026 from 13:00–13:15 at Open Stage 2.
The discussion is particularly relevant for plastic surgeons and aesthetic practitioners interested in gluteal augmentation, fat grafting, HA body fillers, and modern body-contouring strategies.
ISAPS Cancún will bring some of the most relevant conversations in aesthetic plastic surgery into one place.
On 29 October, BioScience will add another perspective to that discussion — looking beyond a single modality and toward a more individualised approach to gluteal augmentation.
Join us at Open Stage 2 to hear the full conversation.
.webp)
.webp)
Subscribe to be the first to know our latest news and projects.
